NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO
Werte in diesem Artikel
NEW YORK, July 31, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
Kristen Scholer delivers the pre-market update on July 31st
- Equities are catching a bid early Thursday after decent earnings reports from tech giants Microsoft and Meta. Apple and Amazon report their earnings after today's market close.
- Figma, which provides browser-based design software, raised $1.2 billion after pricing nearly 37 million shares at $33 each. The price was above an upwardly revised range and valued Figma at more than $19 billion.
- Shoulder Innovations priced five million shares at $15 each in its IPO. The company is a commercial stage shoulder surgery focused Medtech founded in 2009.
Opening Bell
Figma (NYSE: FIG) celebrates its initial public offering
Closing Bell
Shoulder Innovations (NYSE: SI) celebrates its initial public offering
Click here to download the NYSE TV App

Video - https://mma.prnewswire.com/media/2741897/NYSE_Market_Update_July_31.mp4
Logo - https://mma.prnewswire.com/media/2581322/5439934/New_York_Stock_Exchange_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update--figma-valued-at-over-19-billion-in-ipo-302518682.html
Übrigens: Figma und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Figma
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Figma
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Figma
Analysen zu Figma
Keine Analysen gefunden.